Evidence map›Paper›PMID 34298792›Full record

ArticleCancers2021

Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis.

Mimoune Berehab, Redouane Rouas, Haidar Akl, Hugues Duvillier, Fabrice Journe, Hussein Fayyad-Kazan, Ghanem Ghanem, Dominique Bron, Philippe Lewalle, Makram Merimi

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Mimoune BerehabLaboratory of Experimental Hematology, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.
Redouane RouasLaboratory of Experimental Hematology, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.
Haidar AklDepartment of Cellular and Molecular Medicine, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.
Hugues DuvillierLaboratory of Experimental Hematology, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.
Fabrice JourneLaboratory of Oncology and Experimental Surgery, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.
Hussein Fayyad-KazanLaboratory of Experimental Hematology, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.
Ghanem GhanemLaboratory of Oncology and Experimental Surgery, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.
Dominique BronLaboratory of Experimental Hematology, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.ORCID 0000-0002-1634-1104
Philippe LewalleLaboratory of Experimental Hematology, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.
Makram MerimiLaboratory of Experimental Hematology, Institut Jules Bordet-Université libre de Bruxelles, 1000 Brussels, Belgium.
Institut Jules Bordet · BELebanese University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeting non-apoptotic modalities might be therapeutically promising in diffuse large B cell lymphoma (DLBCL) patients with compromised apoptotic pathways. Thymoquinone (TQ) has been reported to promote apoptosis in cancer cells, but little is known about its effect on non-apoptotic pathways. This work investigates TQ selectivity against DLBCL cell lines and the cell death mechanisms. TQ reduces cell viability and kills cell lines with minimal toxicity on normal hematological cells. Mechanistically, TQ promotes the mitochondrial caspase pathway and increases genotoxicity. However, insensitivity of most cell lines to caspase inhibition by z-VAD-fmk (benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone) pointed to a critical role of non-apoptotic signaling. In cells dying through non-apoptotic death, TQ increases endoplasmic reticulum (ER) stress markers and substantially increases cytosolic calcium ([Ca

Indexed as

apoptosisdiffuse large B cell lymphoma (DLBCL)ER-stressnecroptosisnon-apoptotic cell deaththymoquinone

Identifiers

PMID34298792
PMCPMC8304872
OpenAlexW3185229913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.